Working outside the protein‐synthesis rules: insights into non‐ribosomal peptide synthesis
The DOI matches its Crossref record.
Abstract
Non‐ribosomally synthesized microbial peptides show remarkable structural diversity and constitute a widespread class of the most potent antibiotics and other important pharmaceuticals that range from penicillin to the immunosuppressant cyclosporine. They are assembled independent of the ribosome in a nucleic acids‐independent way by a group of multimodular megaenzymes called non‐ribosomal peptide synthetases. These biosynthetic machineries rely not only on the 20 canonical amino acids, but also use several different building blocks, including D‐configured‐ and β‐amino acids, methylated, glycosylated and phosphorylated residues, heterocyclic elements and even fatty acid building blocks. This structural diversity leads to a high density of functional groups, which are often essential for the bioactivity. Recent biochemical and structural studies on several non‐ribosomal peptide synthetase assembly lines have substantially contributed to the understanding of the molecular mechanisms and dynamics of individual catalytic domains underlying substrate recognition and substrate shuffling among the different active sites as well as peptide bond formation and the regio‐ and stereoselective product release. Copyright © 2009 European Peptide Society and John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Natural Products Version 2.0: Connecting Genes to Molecules
Walsh, C. T., & Fischbach, M. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909118a · Cited by 468
Secondary metabolism in Trichoderma – Chemistry meets genomics
Zeilinger, S., Gruber, S., Bansal, R., & Mukherjee, P. K. (2016) · Fungal Biology Reviews · doi:10.1016/j.fbr.2016.05.001 · Cited by 411
mMass as a Software Tool for the Annotation of Cyclic Peptide Tandem Mass Spectra
Niedermeyer, T. H. J., & Strohalm, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044913 · Cited by 300
Explorations of catalytic domains in non-ribosomal peptide synthetase enzymology
Hur, G. H., Vickery, C. R., & Burkart, M. D. (2012) · Natural Product Reports · doi:10.1039/c2np20025b · Cited by 282
Root of the Tree: The Significance, Evolution, and Origins of the Ribosome
Bowman, J. C., Petrov, A. S., Frenkel-Pinter, M., Penev, P. I., & Williams, L. D. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00742 · Cited by 197
Surfactin and Other Lipopeptides from Bacillus spp.
Jacques, P. (2011) · Microbiology Monographs · doi:10.1007/978-3-642-14490-5_3 · Cited by 214
Foldamer hypothesis for the growth and sequence differentiation of prebiotic polymers
Guseva, E., Zuckermann, R. N., & Dill, K. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620179114 · Cited by 76
“Second, a major route of protein synthesis in simple organisms, such as bacteria and fungi, uses nonribosomal peptide synthetases, which do not involve mRNAs (86, 87).”
BackgroundOrigins and Early Evolution of the Ribosome
Fox, G. E. (2016) · Evolution of the Protein Synthesis Machinery and Its Regulation · doi:10.1007/978-3-319-39468-8_3 · Cited by 10
Facilitating the structural characterisation of non-canonical amino acids in biomolecular NMR
Kuschert, S., Stroet, M., Chin, Y. K.-Y., Conibear, A. C., Jia, X., Lee, T., Bartling, C. R. O., Strømgaard, K., Güntert, P., Rosengren, K. J., et al. (2023) · Magnetic Resonance · doi:10.5194/mr-4-57-2023 · Cited by 9
Metadata
- Authors
- Marahiel, M. A.
- Venue
- Journal of Peptide Science
- Publisher
- Wiley
- Published
- 2009-10-13
- Volume
- 15
- Issue
- 12
- Pages
- 799-807
- ISSN
- 1075-2617 (ISSN-L)
- 1099-1387
- OpenAlex
- W1972912380
- Cited by
- 151
- References
- 0
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.